Wright Medical Group (OTCMKTS:GCVRZ) Shares Down 1.9%

Wright Medical Group N.V. (OTCMKTS:GCVRZ)’s share price fell 1.9% on Thursday . The stock traded as low as $0.50 and last traded at $0.51. 448 shares traded hands during mid-day trading, a decline of 100% from the average session volume of 132,025 shares. The stock had previously closed at $0.52.

Several research firms have recently weighed in on GCVRZ. JPMorgan Chase & Co. reiterated a “hold” rating and issued a $81.00 price target on shares of Wright Medical Group in a report on Sunday, April 28th. UBS Group reiterated a “hold” rating and issued a $79.00 price target on shares of Wright Medical Group in a report on Sunday, April 28th. Finally, Goldman Sachs Group reiterated a “hold” rating and issued a $77.00 price target on shares of Wright Medical Group in a report on Sunday, April 28th.

The company’s fifty day moving average is $0.51.

About Wright Medical Group (OTCMKTS:GCVRZ)

Sanofi provides therapeutic solutions worldwide. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; and Aubagio, an immunomodulatory and Lemtrada, a monoclonal antibody to treat multiple sclerosis.

Featured Article: What Is An Exchange-Traded Fund (ETF)?

Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.